Joel M. Reid

Joel M. Reid, Ph.D., is an Associate Professor of Pharmacology at Mayo Clinic, holding primary appointments in the Department of Oncology and a joint appointment in the Department of Molecular Pharmacology and Experimental Therapeutics. His research focuses on preclinical and clinical pharmacology of anti-cancer agents, emphasizing drug metabolism, pharmacokinetics, and novel methodologies like LC-MS/MS analysis. He has led over 75 studies on oncology drugs in late preclinical/early clinical phases.

• Professional Highlights:
• Lead Pharmacologist, Phase I Consortium, Children's Oncology Group (2012–present)
• Member, Pharmacogenomics & Population Pharmacology Committee, Alliance for Clinical Trials in Oncology (2011–present)

Research Interests: Development of sensitive analytical methods for drug metabolites, pharmacogenetic studies in clinical protocols, and systems biology approaches for molecular-level pharmacokinetic characterization. Recent projects include phase 0 clinical trials for Akt inhibitors, population pharmacokinetic modeling of sulindac, and pediatric anti-cancer drug metabolism studies.